About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 286   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others

LETTER TO THE EDITOR

Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity

Raizada Seemant, Al Kandari Jamal, Al Foudari Ahmad

Year : 2011| Volume: 18| Issue : 2 | Page no: 196-197

   This article has been cited by
 
1 Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization
Frank Ong,Jane Kuo,Wei-Chi Wu,Ching-Yu Cheng,Wendell-Lamar Blackwell,Brian Taylor,Wayne Grody,Jerome Rotter,Chi-Chun Lai,Tien Wong
Journal of Personalized Medicine. 2013; 3(1): 40
[Pubmed]  [Google Scholar] [DOI]
2 An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan
Wu, W.-C. and Kuo, H.-K. and Yeh, P.-T. and Yang, C.-M. and Lai, C.-C. and Chen, S.-N.
American Journal of Ophthalmology. 2013; 155(1): 150-158
[Pubmed]  [Google Scholar]
3 An Updated Study of the Use of Bevacizumab in the Treatment of Patients with Prethreshold Retinopathy of Prematurity in Taiwan
Wei-Chi Wu,Hsi-Kung Kuo,Po-Ting Yeh,Chung-May Yang,Chi-Chun Lai,San-Ni Chen
American Journal of Ophthalmology. 2013; 155(1): 150
[Pubmed]  [Google Scholar] [DOI]

 

Read this article